Japan BCG Laboratory,Tokyo Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2001
NCT00242047
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2001

Timeline

NOW
  • Now

Alternative names

Japan BCG Laboratory 4-2-6 Kohinata,Tokyo 112-0006, Japan.

Active Ingredients

Drugs in Phase 4 Trials (1)

bacille calmette-guerin (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Tuberculosis (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 1